Pegylated Interferon Alfa-2b in Reducing Relapse Rates After Nucleos(t)ide Analogue Withdrawal in HBeAg-negative CHB Patients with Low Level HBsAg

Clinical trial NCT06900166 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06900166
Sponsor: Huashan Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2025-04-01
Primary completion: 2029-04-01
Enrollment: 360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.